Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Investors weighing risk and return should consider meta platforms might good as a long-term hold. This guide breaks d...
As EV demand grows and policy shifts unfold, investors are sizing up 2026. This guide breaks down the chances of a re...
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
A major investor sold a substantial stake in an Ethereum ETF, pulling out nearly $19 million in one trade. The move r...
A sizable early-2026 investment in a gold-focused miner is turning heads. This article breaks down what it could mean...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
When apple stock fell today, traders raced to understand whether it signaled a broader shift in tech demand or a temp...
Micron Here! signals a moment of real opportunity for memory-chip investors who want clarity. This guide breaks down ...
A seasoned financial planner argues that a two-ETF approach can cover most retirement needs, pairing a dividend-based...
As U.S. bond markets stabilize in 2026, investors compare BND and AGG for broad fixed-income exposure. Both funds tra...
Insider moves often raise questions for investors. This piece breaks down what Arteris CEO's stock sale could mean, h...